Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2011 Jun 6;286(29):25790–25800. doi: 10.1074/jbc.M111.254383

Identification of a Replication-independent Replacement Histone H3 in the Basidiomycete Ustilago maydis*

Verma Anju 1, Tamas Kapros 1, Jakob H Waterborg 1,1
PMCID: PMC3138321  PMID: 21646347

Abstract

Ustilago maydis is a haploid basidiomycete with single genes for two distinct histone H3 variants. The solitary U1 gene codes for H3.1, predicted to be a replication-independent replacement histone. The U2 gene is paired with histone H4 and produces a putative replication-coupled H3.2 variant. These predictions were evaluated experimentally. U2 was confirmed to be highly expressed in the S phase and had reduced expression in hydroxyurea, and H3.2 protein was not incorporated into transcribed chromatin of stationary phase cells. Constitutive expression of U1 during growth produced ∼25% of H3 as H3.1 protein, more highly acetylated than H3.2. The level of H3.1 increased when cell proliferation slowed, a hallmark of replacement histones. Half of new H3.1 incorporated into highly acetylated chromatin was lost with a half-life of 2.5 h, the fastest rate of replacement H3 turnover reported to date. This response reflects the characteristic incorporation of replacement H3 into transcribed chromatin, subject to continued nucleosome displacement and a loss of H3 as in animals and plants. Although the two H3 variants are functionally distinct, neither appears to be essential for vegetative growth. KO gene disruption transformants of the U1 and U2 loci produced viable cell lines. The structural and functional similarities of the Ustilago replication-coupled and replication-independent H3 variants with those in animals, in plants, and in ciliates are remarkable because these distinct histone H3 pairs of variants arose independently in each of these clades and in basidiomycetes.

Keywords: Cell Cycle, Chromatin Regulation, DNA Replication, Fungi, Histones, Transcription, Basidiomycetes, Histone H3, Histone Variants, Ustilago maydis

Introduction

Core histones provide the packaging proteins for DNA in eukaryotic cells. During the S phase when genomic DNA is duplicated, replication-coupled expression of histone genes provides new protein to assemble newly replicated DNA. Histone chaperones assist in the creation of new nucleosomes to maintain a stable, compacted, repressed state of chromatin. Within this context, regulatory proteins modulate chromatin environments to facilitate access to the DNA for gene transcription. The components and processes that allow RNA polymerases to transcribe a chromatin template, such as epigenetic modifications of DNA and histones, are being identified and intensely studied. The processes of nucleosome displacement from DNA by transcribing RNA polymerases and of nucleosome reassembly from available histones remain poorly understood.

In research going back decades, it was observed that the composition of nucleosomes across transcribed gene regions, identified in part by high levels of histone acetylation, changed over time. Replication-coupled (RC)2 histone H3 variants like H3.2 in birds were replaced by histone H3.3, a constitutively expressed form of animal histone H3. This histone is now known as a replacement histone or as a replication-independent (RI) H3 variant (1, 2). Specialized chaperones such as HIRA and Daxx selectively bind these RI H3 proteins at a small region, residues 87–90, which is uniquely different between RI and RC forms (3, 4). In the S phase, RC and RI variants are both present for replication associated chaperones to assemble nucleosomes. Outside of the S phase, the transcribed genes are only repackaged using new RI H3 proteins. The basis for this selectivity is found in one or more of the following reasons: outside of the S phase, RC H3 proteins are not synthesized, histone H3 molecules from displaced nucleosomes cannot be reused in nucleosome assembly, and transcription-associated chaperones like HIRA use only RI H3 sequence variants.

Many of these processes have been identified and studied in Saccharomyces cerevisiae as a simple model system. However, this yeast makes only a single H3 protein from two histone H3 genes. This H3 is produced in a replication-coupled pattern of expression with significant H3 protein availability outside of the S phase. It acts like an animal H3.3 in that it is used by HIRA (4). In Schizosaccharomyces pombe, a single H3 protein is produced, partly from two RC H3 genes and partly from two constitutive ones (5). Neither model organism can be used to study the contribution of histone H3 variants in replicative and replacement nucleosome assembly.

Study of the functions provided by RC and RI H3 variants in animals and in plants is limited because the multiplicity of genes of both types prevents effective use of gene knock-out and replacement approaches. In each case, the duplication of the ancestral histone H3 and the structural and functional differentiation into replicative RC and replacement RI H3 variants arose independently (68). Gorovsky and co-workers (7) have used the diploid protist Tetrahymena as a model system. In ciliates, distinct RC and RI H3 genes have arisen independently from their appearance in animals and in plants (68). In Tetrahymena with 2 RC and 2 RI loci, complete knock-out of both RC or both RI loci produces viable vegetative cells. In RC knockouts, replication results in dramatically reduced cell proliferation rates and hypoploidy, likely because of insufficient nucleosome formation using only RI H3 histone. Proficient growth required up-regulation of RI loci. Conversely, RI knockouts are viable but fail to produce viable spores (9). The validity of these results for animals or plants has not been confirmed. The sequence differences between the RC and RI H3 variants in Tetrahymena involve many more residues than the distinctive three to five that exist between animal and plant H3 variants.

Ahmad and Henikoff (10) had suggested that the basidiomycete Cryptococcus might contain a replacement H3 variant. Genome sequencing of the related corn smut Ustilago maydis revealed that this haploid organism has two distinct H3 genes. One is paired with the single histone H4 gene, an organization often seen for RC histones, and the other one is a solitary gene, like animal H3.3, with a replacement-like variant sequence at residues 89 and 90 (11) (see Fig. 1). We have evaluated the expression and stability of the Ustilago histone H3 proteins. We have concluded that the solitary H3 gene indeed has all the functional characteristics of a replacement RI H3 variant and that the H4-paired H3 gene is an RC variant. The similarities of the Ustilago H3 variants in gene structural organization, in the differences of the polypeptides produced, in the selectivity of incorporation into replicative and transcription linked nucleosomes, and in protein stability with the RC and RI H3 variants in plants and in animals is remarkable. It provides insight in the conserved nature of nucleosome assembly processes because the RC-RI H3 divergences arose hundreds of millions of years apart, each time at the ancestral root of what have become broad clades of diverse, multicellular eukaryotes (6).

FIGURE 1.

FIGURE 1.

Histone H3 genes of U. maydis. A, structural organization of histone H3 gene U1 for histone variant H3.1 on chromosome 11 and U2 for histone variant H3.2 on chromosome 6 in a divergently transcribed pairing with the single histone H4 gene (11). Transcribed sequences are indicated by bold lines. Arrows mark start and direction of gene transcription. Intron locations in the 5′-untranslated region and at codon 98 of H3.1 and at codon 15 of H3.2 are marked. A 1-kb size marker is shown. B, comparison of U1 and U2 protein products with positions 1–135 of the mature proteins and sequence differences marked by asterisks and highlighted as bold capital letters.

We have begun to exploit the possibilities for homologous gene replacement in U. maydis (12) and complementation by plasmid-based histone H3 mutants to evaluate the contribution of these two H3 variants in nucleosome assembly during transcription and replication. The viability of strains with KO U1 or U2 loci, coding for the RI H3.1 and RC H3.2 variants, respectively, is reported.

EXPERIMENTAL PROCEDURES

Culture of Ustilago

U. maydis 521, strain 9021 obtained from the Fungal Genetics Stock Center (University of Missouri-Kansas City, Kansas City, MO) and defined as WT, was grown in synthetic dextrose (SD) medium (6.7 g of Difco yeast nitrogen base without amino acids (Benton-Dickinson, Sparks, MI) with 20 g of glucose/liter) at 30 °C on 2% agar or in liquid culture at 150 rpm with typical experimental use at ∼107 cells/ml. Cell density was determined by hematocytometer counting. Stationary phase conditions developed for WT cells above 2 × 107 cells/ml in SD medium. Labeling in vivo with [3H]acetic acid (20 Ci/mmol; MP Biomedicals, Irvine, CA) was performed at 4 mCi/liter for 5 min, unless specified otherwise, after 10 min of preincubation at 10 μg/ml cycloheximide (Sigma), added from 2 mg/ml stock in ethanol. Labeling with [4,5-3H]l-lysine (60 Ci/mmol; MP Biomedicals) was performed at 0.4 mCi/liter for 30 min, unless specified otherwise, and with [35S]l-methionine (540 Ci/mmol; MP Biomedicals) at 0.1 mCi/liter for 20 min. Cell cycle progression was arrested in the S phase by the addition of 10% (w/v) hydroxyurea to 1 mg/ml (13) in 1-liter log cultures at 2.2 × 106 cells/ml for 90 min. The cells were released from the block by washing with preconditioned SD medium. Tritiated lysine (50 μCi) was added to each culture during the last 30 min prior to cell collection after the culture was concentrated to 250 ml by centrifugation (5 min, 800 × g). The distribution of cells across the G1, S, and G2/M phases was determined by flow cytometry as described (13) in a FACScalibur 877 (Benton-Dickinson) with ModFit LT (Verity Software) data analysis.

Purification of Histone H3

Histones were extracted and purified from cell pellets essentially as described (14). Cells from 0.25 to 2.0 liters of culture were collected by centrifugation (5 min, 800 × g) and resuspended into two to four pellet volumes of 40% GuCl in KPi (40% guanidine HCl, 0.05 m KH2PO4, 0.05 m K2HPO4, adjusted by KOH to pH 6.8, with 1.4 mm 2-mercaptoethanol). The cells were sonicated on ice in aliquots of 15 ml for 5 min twice with a Branson Sonifier 400 with medium tip at 25% initial output with cooling break, which resulted in 90+ % cell breakage, clarified (10 min, 30,000 × g), incubated on ice for 15 min at 0.25 n HCl, clarified (30 min, 30,000 × g), diluted with 0.1 m KPi, pH 6.8, to the refractive index of 5% GuGl in KPi, adjusted to 1.4 mm 2-mercaptoethanol, and incubated overnight under rocking with 1 ml of settled BioRex70 resin (200–400 mesh; Bio-Rad) per extract from 2 × 1010 cells, an experimentally optimized ratio for the Ustilago procedure. After repeated washing by 1 × g settling of the resin from 5% GuCl in KPi until the supernatant was clear, resin was placed in a small column and washed with 8 volumes of 5% GuCl in KPi, and histones were eluted by 10 volumes 40% GuCl in KPi. Histones were dialyzed in 3,500 molecular weight cut-off Spectra/Por 3 dialysis membranes (Spectrum Labs, Rancho Dominguez, CA) thrice against 100 volumes of 2.5% acetic acid with 1.4 mm 2-mercaptoethanol and recovered by lyophylization. Histone H3 was purified by reversed phase HPLC on Zorbax Protein-Plus columns (0.4 × 25 cm, New England Nuclear) as described (14). Crude histones were dissolved in 0.25 ml of 8 m urea in 1 m acetic acid and injected in the column, equilibrated at 1 ml/min with 40% acetonitrile (Fisher) in 0.1% TFA (Sigma), washed for 2 min in this solvent, and eluted by a gradient from 40 to 55% acetonitrile in 0.1% TFA over 45 min. The two histone H3 variants co-eluted 43 min after injection, as monitored by absorbance at 214 nm. They were identified by acid urea Triton (AUT) gel electrophoresis of lyophilized column fractions based on protein size and characteristic affinity for Triton X-100 (15, 16). Semi-preparative purification of histone H3 used Vydac C4 columns (214TP510, 1.0 × 25 cm; Grace, Deerfield, IL) with the same elution conditions at 3 ml/min.

Polyacrylamide Gel Analysis

AUT gel electrophoresis was performed in 15- or 30-cm-long gels with Triton X-100 (Bio-Rad) at 6 mm, a concentration optimized for Ustilago histone H3 variant separation, as described (15, 16). Proteins were quantitated by densitometry of gels, stained with Coomassie Brilliant Blue R-250, and destained in 7% acetic acid, 20% methanol. Specific radioactivity was determined by densitometry of fluorographic exposures exactly as described (17, 18).

qRT-PCR Quantitation of H3 Gene Transcripts

Total RNA was isolated with TRIzol reagent (Invitrogen) using 0.4–0.6 mm glass beads for cell breakage for 3 min in a Mini-Beadbeater-16 (Biospec Products, Bartlesville, OK). Genomic DNA was digested with DNase I. The qRT-PCR procedure with separate cDNA synthesis step was performed according to the manufacturer's instructions using the Superscript III Platinum two-step qRT-PCR kit with SYBR Green (Invitrogen) in an Applied Biosystems 7500 thermal cycler (Invitrogen). Ustilago peptidyl-prolyl isomerase (ppi) (GenBank NW_101009, locus UM03726.1) was used as a constitutively expressed reference gene (19, 20). Primers used for the amplification of histone genes (see Fig. 1A) U1 (U1F and U1R), U2 (U2F and U2R), and H4 (H4F and H4R) and for the ppi gene (ppiF and ppiR) are listed in Table 1. Histone mRNA qRT-PCR levels were quantitated as 2−ΔCt, relative to ppi levels, following the manufacturer's instructions.

TABLE 1.

PCR primers

Primer name Primer sequence PCRa
U1F AGCGTCTCGTTCGTGAGATT 344 (235)
U1R CGTTAGAGGCAAATGTGGAGT
U2F TCCAACACATAACTTCTCACTCG 292 (175)
U2R AGGCTTCTTGACACCACCAG
H4F AAAGGCGGCAAGGGTCTCG 362 (260)
H4R TTGAGTGCGTAAACAACGTCGAGC
ppiF TTCCCAAGACTGCCAAGAAC 267 (267)
ppiR CGACGGTGGTGATGAAGAAC
U1KOLBF TCGATGAGCTCCCTGTTCGCTACCCTCTCT 863
U1KOLBR TGGTGGCCATCTAGGCCAGGGTGTTGGAACG
U1KORBF ATAGGCCTGAGTGGCCTCGTCTCTCTTTCGCAT 1043
U1KORBR AGTCTGAATTCCACCGATCCTCCTATACCA
U2KOLBF TCAGAGTCGACCGCACTTATCGTGCTAGTCC 1020
U2KOLBR TGGTGGCCATCTAGGCCAGAAGCCGAATGAGCAGTGT
U2KORBF ATAGGCCTGAGTGGCCTATAGTGGGCGTCTGAATC 1015
U2KORBR AGTCTAAGCTTTCCTTGTTCACCGCTCGT

a PCR product in bp from DNA templates and, in parentheses, from RNA/cDNA templates.

Transformation of Ustilago

Transformation of U. maydis was modified from published procedures (12, 21) as follows. Cells (5 × 106), subcultured under continuous logarithmic growth in SD medium for at least 4 days, were collected at 105 cells/ml culture density by centrifugation for 5 min at 1100 × g, gently washed with 30 ml of SCS (20 mm sodium citrate, pH 5.8, 1 m sorbitol), and resuspended in 1 ml SCS. Protoplasts were produced by adding 2 ml of 128 mg/ml Vinoflow FCE (Novo, Gusmer Enterprises, Mountainside, NJ) in SCS and gentle mixing for 10 min, with microscopic verification of protoplasting. Protoplasts were collected by centrifugation for 10 min at 1100 × g, washed twice with 1 ml of SCS and once with 1 ml of STC (1 m sorbitol, 10 mm Tris·HCl, pH 7.5, 100 mm CaCl2), and resuspended in 1 ml of ice-cold STC. A mixture of 5 μl of transforming DNA at 1 mg/ml in STC and 1 μl of 15 mg/ml heparin (Sigma) in STC was added to protoplasts (106 in 0.05 ml) on ice and incubated for 10 min. A solution of 0.5 ml of 40% (w/v) PEG 4000 (Sigma) in STC was added and incubation on ice was continued for 15 min followed by the addition of 0.5 ml STC. Protoplasts were centrifuged for 5 min at 1100 × g, and the pellet was resuspended in 0.2 ml of STC. Aliquots (0.02 ml) were plated on 1% SD agar containing 1 m sorbitol and 2 μg/ml carboxin and grown at 30 °C. Transformants were collected after 4–5 days. Carboxin (CBX) (5,6-dihydro-2-methyl-1,4-oxathi-ine-3-carboxanilide; Vitavax) and CBX resistance plasmid pGR3 were kind gifts from S. Gold (Athens, GA). Used without linearization as a transformation reference, pGR3 yielded thousands of transformants per plate in this procedure.

Transformation Constructs

Genomic DNA was isolated by cetyl trimethylammonium bromide (22), as modified (23), by the addition of 1% cetyl trimethylammonium bromide (Sigma) in 0.1 m Tris·HCl, pH 7.5, 0.7 m NaCl, 10 mm EDTA, 14 mm 2-mercaptoethanol to pelleted cells, vigorous vortexing for 3 min with 0.4–0.6-mm glass beads, incubation for 45 min at 65 °C, the addition of 1 volume of chloroform:isoamyl alcohol (24:1, v/v), centrifugation for 5 min at 12,000 × g, DNA precipitation from the aqueous phase with 0.9 m ammonium acetate in 2-propanol, and a wash of the DNA with 70% ethanol.

For the U1 KO construct, a 863-bp U1 left border (LB) sequence was amplified by PCR in a MJ Research PTC-225 PCR cycler (GMI, Ramsey, MN) using primer pair U1KOLBF and U1KOLBR, and a 1043-bp U1 right border (RB) sequence by primer pair U2KORBF and U2KORBR. The transformation construct was assembled by ligation of EcoRI- and SacI-digested plasmid pGEM-4Z (Promega, Madison, WI) to SacI- and SfiI-digested U1 LB, the CBX cassette excised by SfiI from pMF1-c (12), kindly provided by M. Feldbrügge (Düsseldorf, Germany), and the SfiI- and EcoRI-digested U1 RB. The construct was linearized by XbaI or SmaI for use in transformation through double-strand DNA repair-based homologous recombination (24). The equivalent U2 KO transformation construct was ligated using HindIII- and SalI-restricted pGEM-4Z, the SalI- and SfiI-digested 1020-bp U2 LB amplified by PCR primer pair U2KOLBF and U2KORBR, the CBX cassette excised by SfiI from pMF1-c, and the SfiI- and HindIII-digested 1015-bp U2 RB amplified by primer pair U2KORBF and U2KORBR and linearized by SacI for use in transformation. Constructs were verified by restriction digestion and sequencing.

CBX-resistant colonies were subcultured into liquid SD at 3 μg/ml carboxin. Genomic DNA was prepared, and homologous recombination at the targeted U1 and U2 loci was analyzed by PCR using a variety of primer pairs that uniquely recognized sequences within the transforming constructs, the carboxin resistance cassette, and sequences inside and beyond the border sequences. These primer sequences will be provided upon request. Two U1KO transformation experiments produced 65 CBX-resistant clones that grew in liquid SD and continued growth when selection was removed. Eight strains contained KO recombination events at the U1 locus and likely were heterokaryons. Clone 47 was identified as a homokaryon U1 knock-out containing the CBX cassette with error-free homologous recombination in LB and RB sequences, as confirmed by sequencing. Multiple confirmed U2 knock-out strains were obtained from recombinant heterokaryon strains that contained both wild-type and knocked out U2 loci in varying ratios, as measured by PCR analysis (data not shown). Continued culture under selection produced stable, slow growing homokaryon lines that subsequently could be maintained without carboxin selection and that contained only the CBX-interrupted U2 locus as verified by PCR analysis and sequencing. Transformed KO lines maintain viability when stored at −80 °C in 15% glycerol.

RESULTS

Identification of Ustilago H3 Variants

Sequencing of the genome of the haploid basidiomycete U. maydis revealed the existence of two single-copy histone H3 genes (11): one on chromosome 11 as a solitary histone, named U1 (GenBank AACP01000135.1, locus UM03916.1) and one, named U2, in a divergently transcribed gene pair with histone H4 on chromosome 6 (GenBank AACP01000090.1, locus UM02709.1) (Fig. 1A). These histone forms differ only in a few amino acids, including residues 89–90 (Fig. 1B). This region defines the replacement character of animal histone H3.3 (4, 25), that interacts with the specific replication-independent histone chaperones HIRA and Daxx (3) and that exists in the independently evolved replacement H3 variants of higher plants (8, 2628) and ciliates (7). The characteristic sequence at residues 87–90 was the basis for the suggestion that the basidiomycete Cryptococcus might also contain this type of replacement histone H3 (10). We chose to use U. maydis as the model system (29) to evaluate the existence of a replacement histone H3 in basidiomycetes. We anticipated that the methionine-containing U2 gene, which shares its promoter region with the single histone H4 gene (Fig. 1), would be expressed in the S phase.

BioRex70-based histone isolation from whole cells under denaturing conditions to preserve post-synthetic modifications and protein integrity was followed by reversed phase chromatography. The co-eluting histone H3 variants were separated by AUT gel electrophoresis (Fig. 2A) and named in order of increasing gel mobility H3.1 and H3.2, based on the standard method of core histone variant nomenclature (30). [35S]Methionine labeling identified U2 as the gene that codes for histone variant H3.2 (Fig. 2B) based on the single methionine in the mature protein (Fig. 1B). This indirectly identified U1 as the gene that produces histone H3.1 (Fig. 1A).

FIGURE 2.

FIGURE 2.

Separation, identification, and post-translational modification of H3 histones. A, separation of H3 variants, co-eluted from reversed phase HPLC, in an acid urea (AU) gradient gel with Triton X-100 from 0 to 10 mm where H3 variants co-electrophorese under AU conditions at 0 mm Triton. The slant in electrophoretic mobility across the gradient, marked by methylene blue at the discontinuous running front, by nonhistone proteins in this partially purified HPLC H3 pool and by two guidance lines, results from the glycerol gradient used to stabilize the gradient gel (16). The characteristic high affinity for Triton of core histone H3 is modulated by differences of exposed side chains within the histone fold of the H3 variants (Fig. 1B) (48, 49). The broken line marks the optimal concentration of 6 mm Triton X-100 in 8 m urea and 1 m acetic acid for the separation of the H3 variants of U. maydis. B, pattern of H3 variants in AUT gels, pulse-labeled in vivo with [35S]methionine for 20 min at 0.1 mCi/liter (lanes A and B) or with [3H]lysine for 30 min at 0.4 mCi/liter (lanes C and D) or chased for 24 h in fresh SD medium into stationary phase (lanes E and F). Coomassie-stained gel lanes are marked by c, and 33-day fluorographic exposures are marked by f. Nonacetylated and hexa-acetylated H3 species are marked by 0 and 6, respectively. C, pattern of histone H3 variants in logarithmically growing cultures, incubated with 4 mCi/liter [3H]acetic acid for 5 min (lanes A and B) or 20 min (lanes C and D). Coomassie-stained gel lanes are marked by c, and 18-day fluorographic exposures are marked by f. Nonacetylated through hexa-acetylated H3 species are marked by numbers 0–6, respectively.

Relative Abundance of H3 Variants

The relative amounts of the two histone H3 variants varied with culture conditions. Continuous subculture to maintain logarithmic growth resulted in cells with up to 80% of histone H3 in the H3.2 form (lanes A and C in Fig. 2C and lane 0 h in Fig. 3A). When cultures were allowed to reach near stationary phase (2 × 107 cells/ml), the relative amount of H3.1 protein increased to more than 30%, whereas continued culture into the full stationary phase, when cell budding ceases, cell walls thicken, and cell density stabilizes, produces cultures with up to 50% H3.1 protein (lane E in Fig. 2B and Fig. 3). Such a gradual replacement of proliferation associated protein by another form, named a replacement variant (25), which preferentially occurs across transcribed gene regions (31), was one of the first indications for the existence of replacement H3 histone variants (1, 2). The changes in H3 variant abundance support the notion that H3.2 is a replication-coupled (RC) variant and H3.1 a replication-independent (RI) form.

FIGURE 3.

FIGURE 3.

Changes in H3 variant abundance and steady state acetylation. A, histone H3 variants were isolated from mid-log phase cultures (0.4 × 107 cells/ml), marked as 0 h (log), and after 2, 6, and 12.5 h continued culture into stationary phase (stat). B, the increased abundance of H3.1, expressed as a percentage of total histone H3 (solid line), during continued growth coincides with reduced levels of histone H3 acetylation (broken line) and cessation of cell budding.

Histone Acetylation of H3 Variants

The loss of nucleosomes across transcribed chromatin regions followed by the preferential use of replacement H3 variant forms to create new nucleosomes predicts that a replacement H3 form will show raised acetylation levels (26, 32). H3.1 was acetylated 10–30% higher than H3.2 under all growth conditions, as measured in stained AUT gels. H3.1 had 1.2–1.6 acetylated lysines (AcK) per molecule during logarithmic growth (lanes A and C in Fig. 2, B and C). This level decreased in the stationary phase (Fig. 3). New H3.1, visualized by lysine pulse labeling with up to six radioactive acetyl-lysines (tritiated AcK) per molecule, contains 2.7 AcK per new H3.1 (lane D in Fig. 2B) and 1.3 per bulk H3.1 (lane C in Fig. 2B). This is higher than the 2.4 AcK per new H3.2 (lanes B and D in Fig. 2B) at a steady state of 1.1 AcK per bulk H3.2 (lanes A and C in Fig. 2B).

Pulse labeling with tritiated acetate for 5 min under conditions of histone synthesis inhibition by cycloheximide reveals that a subfraction of histone H3.1 (with 1.6 AcK/H3) (lanes A and C in Fig. 2C) is subject to very rapid acetylation at up to six sites with an average of 3.4 tritiated AcK/H3.1 (lane B in Fig. 2C). Turnover is so rapid that labeling for 20 min results in a much reduced specific radioactivity, even without applying a chase protocol. The same situation has been observed and analyzed in Chlamydomonas (17). The loss of acetate label caused by turnover (lane D in Fig. 2C) is consistent with a half-life of less than 4–5 min. For histone variant H3.2, acetylation levels are lower. Pulse labeling produces 2.4 tritiated AcK/H3.2 (lane B in Fig. 2C) in bulk H3.2 with 1.4 AcK/molecule (lanes A and C in Fig. 2C). Turnover appears a bit slower with a half-life of 5–6 min (data not shown). These rates of histone acetylation turnover are consistent with rates at which N-terminal lysines are acetylated and rapidly deacetylated in transcriptionally active chromatin of other species (33).

Histone Synthesis of H3 Variants

The rise in H3.2 abundance in growing cultures suggested a coupling between H3.2 synthesis and the S phase when newly replicated DNA is packaged into chromatin. Conversely the rise in H3.1 abundance when cell proliferation ceases (Fig. 3A) predicts the absence of such a relationship and suggests cell cycle-independent histone synthesis. Such a constitutive pattern is typical for replacement H3 histones in animals (4), plants (34), and ciliates (9). This prediction was tested experimentally by RT-PCR analysis of U1 and U2 transcript levels and by measuring histone H3 variant protein synthesis rates in hydroxyurea-synchronized U. maydis cultures (13).

Early log phase cultures were treated for 90 min with 1 mg/ml hydroxyurea to arrest cells in the S phase (13) and released into conditioned SD medium, and histones were purified after 30 min of pulse labeling for histone synthesis with tritiated lysine. Such a single block procedure produced a reasonable degree of synchrony in logarithmically growing cultures, as determined by flow cytometry across the first few hours after release from the block (Fig. 4G). A similar degree of synchrony was observed after a double hydroxyurea block protocol (data not shown).

FIGURE 4.

FIGURE 4.

Histone H3 variant genes differ in cell cycle expression patterns. A, histone H3 proteins, labeled at 0.5-h intervals after release from treatment with hydroxyurea (1 mg/ml) for 0.5 h with tritiated lysine, eluted between 41 and 46 min after HPLC column loading (see “Experimental Procedures”) as determined by absorbance (Abs.) at 214 nm. The presence of lysine label was determined in each 1-ml fraction (cpm/fr) by liquid scintillation counting. Based on lysine labeling, peaks in histone H3 synthesis rates were observed in samples labeled from 0.5 to 1.0 h and from 2.5 to 3.0 h after release from the hydroxyurea block. The time after release shown is the time that cells were collected for histone purification. B, pooled histone H3 preparations collected at 0.5-h intervals after lysine labeling for 0.5 h were separated by AUT gel electrophoresis and stained with Coomassie (Coom.). The relative amounts of the H3.1 and H3.2 proteins, and the amounts of all acetylated species (nonacetylated through hexa-acetylated species are marked) were determined by densitometry. C, radioactivity in all bands was quantitated by densitometry of fluorographs exposed for varying length of time (a 30-day exposure is shown in C), and the calculated specific radioactivity is shown in E. D, the cell density in cultures released from hydroxyurea was determined by hemocytometer counting (broken line). The biphasic histone H3 HPLC elution pattern, which was most prominent at 1 and 3 h after release from hydroxyurea, was shown to consist of a late-eluting form of newly synthesized histone H3 and an early eluting bulk form of histone H3 (see Fig. 5). The relative amount of late-eluting, new H3, to the right of the line in each of the graphs of A, is shown by the continuous line, expressed as a percentage of total H3 protein. The gray bar represents hydroxyurea treatment (from −90 min to 0 min). E, specific radioactivity in histone H3.1 (solid triangles) and H3.2 (open triangles), calculated from densitometry of the data in B and C, is plotted at the mid-point of the 30-min pulse labeling period. F, the amounts of mRNA transcripts from H3.1 U1 (solid triangles), from H3.2 U2 (open triangles), and from H4 genes (open squares) was determined by qRT-PCR relative to constitutive ppi gene transcript levels. G, FACS cell cycle analysis of samples after release from the hydroxyurea block, scored by ModFit LT. The three populations scored were, from left to right in each panel, cells in the G1 phase (dark area), cells during replication (light area), and cells in the G2/M phase (dark area).

Lysine pulse labeling showed that most label was observed across the tail of the histone H3 peak in reversed phase HPLC (Fig. 4A). At this position a late-eluting peak was seen in S phase-enriched cultures (Fig. 4, A and D). Subsequent analysis (Fig. 5) showed that newly synthesized histone H3 of U. maydis elutes as a discrete entity later than the bulk H3 form into which it is converted over time. For the experiment presented in Fig. 4, both new and bulk histone H3 protein was pooled together and analyzed on AUT gel by Coomassie staining (Fig. 4B) and fluorography (Fig. 4C). The peak incorporation of label at 1 and 3 h (Fig. 4A) was predominantly found in H3.2 (Fig. 4C). The specific radioactivity of H3.2 at the time of the second S phase (Fig. 4G) was reduced in prominence because the same amount of tritiated lysine was supplied to twice the number of cells (Fig. 4D). The replication-coupled pattern of H3.2 gene expression was confirmed by qRT-PCR analysis of H3.2 U2 gene transcript levels. The H3.2 expression pattern was like that of the single U. maydis H4 gene (Fig. 4F). The slight rise in H3.1 synthesis, detected by labeling at the height of the first S phase after release from hydroxyurea (Fig. 4E), was not seen in H3.1 transcript levels (Fig. 4F). These results identify H3.1, as predicted, as a replication-independent H3 variant. The increased incorporation of constitutively transcribed H3.1 during the S phase is likely to reflect co-incorporation with H3.2 protein by chaperones without H3 sequence specificity at a time when large amounts of newly replicated DNA are available for assembly into chromatin.

FIGURE 5.

FIGURE 5.

Histone H3 turnover identifies the H3.1 variant as a replacement histone. A, logarithmically growing cultures (0.5 liter) at 107 cells/ml were incubated for 15 min with 0.1 mCi of tritiated lysine, collected, and chased in SD medium supplemented with 100 mg/ml lysine. Examples of the HPLC absorbance at 214 nm and cpm per 0.5-ml fraction are shown after pulse labeling (0 min) and after 30-, 66-, and 115-min chase. B and C, pooled fractions for main H3 (m) and new H3 (n) were fractionated by AUT gel electrophoresis, Coomassie-stained (B), and fluorographed for 28 days (C). The chase times (min) for all samples are shown between B and C. The H3.1 and H3.2 variants are marked at nonacetylated (marked with 0) up to hexa-acetylated (marked with 6) species. D, the relative specific radioactivity of nH3 (solid line with solid triangles) and mH3 (broken line with open squares) in HPLC chromatography is shown as the percentage of cpm/absorbance after pulse labeling. The overall decrease in total H3 specific radioactivity (gray circles) below the initial pulse label level (dotted line) is shown with a linear fitted line. E and F, the relative specific radioactivity of H3.1 (E) and H3.2 (F) variants, calculated from fluorography (28 days) and Coomassie densitometry in C and B, respectively, was standardized at the start of the chase period when 38 ± 10% (n = 8) of the label is located in H3.1 (C, 0 min lanes). Plotted as in D, the linear fitted line demonstrates ∼50% turnover of new histone H3.1 during a 150-min chase (E) and the absence of detectable turnover of new histone H3.2 (F). In combination, these effects produce the same H3.1 abundance that is seen as the Coomassie-stained steady state condition where 26 ± 1% (n = 8) of histone H3 exists as H3.1 protein (B).

Turnover of Histone H3.1 Protein

Lysine incorporation into new H3 variants in asynchronously growing cultures showed that 60% of the label was incorporated into the H3.1 variant, which represented only 31% of the total H3 protein (lane D in Fig. 2B). A similar observation was made for the alfalfa RI H3 (26) and lead to the discovery that this alfalfa H3 variant was subject to protein turnover with a half-life of ∼20 h as part of the displacement of nucleosomes from transcriptionally active chromatin. This identified the plant RI H3 as a replacement histone variant (26). For the Ustilago system, this prediction was evaluated and experimentally confirmed for histone H3.1 as follows.

We took advantage of the novel observation that lysine pulse label was observed primarily in a peak of new H3 (nH3), which eluted 2 min after the main H3 (mH3) peak. The pulse label was shortened from 30 to 15 min, and the HPLC sampling rates were doubled (Fig. 5A). During the chase period, the label shifted from the nH3 HPLC peak with 22 ± 4% (n = 8) of the absorbance in H3 (Fig. 5A) to the mH3 peak with a half-life of ∼30 min (Fig. 5D). The H3 specific radioactivity in HPLC fractions showed that 20% of label was lost in 2.5 h (Fig. 5D).

Pooled m and n fractions were run in parallel on AUT gels, stained (Fig. 5B) and fluorographed (Fig. 5C), and the specific radioactivity of each variant was determined. New protein (nH3) for both variants matured to the mH3 peak with a half-life of 30 min and appeared complete by 90–120 min (Fig. 5, E and F). The specific labeling of H3.2 was stable for at least 2.5 h (Fig. 5F). In contrast, H3.1 was clearly subject to protein turnover with a 50% loss in 2.5 h (Fig. 5E). In these cell cultures with a doubling rate of 1.7 h, this is ∼1.5 cell cycles. The pattern of specific radioactivity was fitted to linear decay patterns (Fig. 5, D and F). Data precision was insufficient to determine whether turnover was linear or, as expected, exponential.

Histone H3 Synthesis under Nonproliferative Conditions

Log cultures were treated for 90 min with hydroxyurea as before (Fig. 4) to stop cell proliferation. The cells were labeled for 30 min in fresh SD medium with tritiated lysine, and a pulse-labeled aliquot was collected. To other aliquots, hydroxyurea was added to 1 mg/ml to block cell cycle progression for an additional 2, 4, 6, or 10 h. Culture density was monitored during this chase period, and cell numbers remained unchanged. The specific labeling of H3.1 and H3.2 variants was determined by densitometry of stained and fluorographed AUT gels. The specific radioactivity of H3.2 remained unchanged throughout the experiment. The labeling of H3.1 decayed exponentially with a half-life of 3.5–4 h (data not shown). This result confirmed that new H3.1 is subject to extensive turnover both in cycling and noncycling cells.

The replication-independent pattern of H3.1 was confirmed by measuring H3.1 synthesis when hydroxyurea inhibited DNA replication (HU lanes in Fig. 6, A and B) and in stationary cultures when cell proliferation had ceased (Stat lanes in Fig. 6, A and B, and Fig. 6, E). In hydroxyurea, labeling of new H3.1 and H3.2 was reduced 5–10-fold (HU lanes of Fig. 6B, 14 and 22%, respectively) relative to growing cells (Log lanes in Fig. 6B). In stationary cultures, labeling of RI H3.1 was little affected (compare Stat-n and HU-n lanes in Fig. 6B). In contrast, labeling of new H3.2 dropped to less than 1% (compare Stat-n and Log-n lanes in Fig. 6B). The reduction of H3.1 labeling in nonproliferative cultures is likely to reflect loss of replicative nucleosome assembly sites, whereas transcription linked sites persisted. In contrast, reduction of replication reduces and cessation of cell proliferation eliminates the replication-coupled synthesis and deposition of H3.2.

FIGURE 6.

FIGURE 6.

Histone H3 variant synthesis in wild-type, U1KO, and U2KO cultures. A, histone H3 proteins extracted from WT cells, labeled for 15 min with tritiated lysine (0.3 mCi/L) during log culture (Log) at 1.5 × 107 cells/ml, after 6 h of continued culture at 1 mg/ml hydroxyurea (HU) and after 24 h of continued culture into stationary phase (Stat), were fractionated by HPLC into main (m) and new (n) pools (see Fig. 5) and analyzed by AUT gel electrophoresis, stained with Coomassie (Coom.), and fluorographed for various lengths of time. B shows a 6-day exposure for Log and a 35-day exposure for HU and Stat samples. Nonacetylated (marked with 0) through hexa-acetylated (marked with 6) forms of H3.1 and H3.2 are marked. C, cultures (0.8 liter) of U2KO isolate 96 (U2KO), WT, and U1KO isolate 47 (U1KO) cells were labeled for 30 min with 0.2 mCi/liter tritiated lysine during logarithmic growth (Log) and continued growth into stationary phase (Stat) at the time and culture densities marked by stars in G, E, and F, respectively. Histone H3 variants, separated in AUT gels, were stained with Coomassie (C) and fluorographed. The example of an 11-day fluorography is shown in D. Nonacetylated (marked with 0) through hexa-acetylated (marked with 6) forms of H3.1 and H3.2 are marked. Note that H3 yields from long-term stationary cultures of WT, U1KO, and U2KO were reduced on a per cell basis to 62 ± 6% (n = 6) for all strains, likely because of cell wall thickening and the resulting decreased efficiency of cell breakage by sonication. E, cell density, measured by hemocytometer, of WT cells, with subculturing and dilution with SD medium marked by broken lines. Stars mark Log and Stat lysine labeling times and cell densities. Total cell amounts were plotted in H, marked by wt. F, like E for U1KO isolate 47. G, like E for U2KO isolate 96. H, total increase in cell numbers calculated from E–G for WT, U1KO, and U2KO strains. Cell doubling times calculated from exponential curve fitting (Sigmaplot) are shown.

Taken together, these experiments demonstrate that H3.1 is a constitutively expressed, and thus replication-independent (RI), histone H3 with all functional characteristics that are seen in animal RI H3.3 and the equivalent plant replacement H3 variants. In contrast, the prominent pattern of S phase enhanced expression of H3.2, which was as strongly replication-coupled as the histone H4 gene, and cessation of its synthesis when cell proliferation ceases, clearly identifies H3.2 as a replication-coupled variant.

Are RC and RI H3 Variants Required?

The genome of haploid U. maydis contains single RI H3.1 (U1) gene and a single RC H3.2 (U2) gene, coupled through a shared promoter with the single H4 gene (Figs. 1A and 4F). This represents a uniquely simple system to evaluate whether either H3 variant is essential. Transformation cassettes for homologous recombination at U1 and U2 loci were created based on the knock-out plasmid pMF1-c with CBX as selectable marker (12). Homologous recombination target sequences (∼1 kb) were produced by PCR. The LB sequences were upstream of the TATA promoter sites of the U1 and U2 genes. The RB sequences were downstream of the end of the 3′-UTRs of the U1 and U2 genes, as determined from available GenBank expressed sequence tag clones. A low number of stable, PCR- and sequencing-verified U1 knock-out (U1KO) and U2 knock-out (U2KO) homokaryon transformants were obtained (see “Experimental Procedures”). H3 proteins from U2KO and U1KO isolates on AUT gels showed the absence of H3.2 and of H3.1 protein in these strains, respectively (Fig. 6C). This showed that neither knock-out causes lethality and that vegetative growth is possible with either H3 variant protein. A similar conclusion was reached in Tetrahymena (9). Synthesis and acetylation of H3.1 in U2KO and of H3.2 in U1KO cells in growing and stationary cultures was indistinguishable from WT results (Fig. 6D).

Some mutant phenotypes are described below. A full phenotypic analysis of U1KO and U2KO strains will be presented elsewhere. Growth rate comparisons of WT cells (Fig. 6E), U1KO cells (Fig. 6F), and U2KO cells (Fig. 6G) revealed that cell cycles had lengthened in the KO strains (Fig. 6H). The effect was moderate, with a 25% increase in cell doubling time for the U1KO strains without RI H3.1 protein. U1KO cells were a bit smaller than WT ones with normal budding. Histone H3 protein yield was unaffected on a per cell basis in log and stationary cultures, leading to a high protein load per AUT lane when histones were extracted from the same number of U1KO and WT cells (Fig. 6C). U1KO cultures reached stationary phase at cell densities (2 to 3 × 107 cells/ml) similar to WT cells (Fig. 6, compare F with E) with WT-like changes in cell wall morphologies.

U2KO cells without RC H3.2 grew more slowly, as measured during continuous logarithmic growth, achieved by repeated dilution of cultures (Fig. 6G) with cell doubling in 4.8 h, more than twice that of WT cells (Fig. 6H). U2KO cells were quite a bit larger than WT ones. In liquid culture, cell lengthening with septa formation and branching was observed. This mycelial-like growth was strongly enhanced in surface cultures on SD agar. Histone H3 yield on a per cell basis was increased over WT (Fig. 6C), consistent with the observation of multiple nuclei in mycelial-like cells (data not shown). Consistent with the larger cell size, U2KO cultures reached stationary culture conditions at ∼107 cells/ml (Fig. 6G), two to four times lower than WT (Fig. 6E) and U1KO strains (Fig. 6F).

DISCUSSION

It is remarkable how similar the Ustilago histone H3 variants are to those in animals and in plants. Every prediction made for Ustilago, based on the established characteristics of RI and RC H3 variants in plants and in animals, was confirmed. Evolutionary analysis has demonstrated that the structural duplication and functional divergence of RI and RC variants arose independently, hundreds of millions of years apart, in those ancestral species that gave rise to the clades of animals, plants, ciliates, and basidiomycetes (6). The RC and RI H3 variants arose 400 million years ago in the ancestral species of all multicellular metazoa. For plants, this event occurred likely more than 800 million years ago. A similar H3 duplication and functional specialization occurred independently in the ciliate ancestor (7). In each case, replication-coupled H3 genes persisted, in general, linked to histone H4 genes, as seen for the U2 gene in Ustilago. These genes consistently lost the ability to interact with transcription linked nucleosome assembly factors like the HIRA chaperonin because of primary protein sequence changes limited to residues 87–90 (4). The ancestral H3 form, capable of transcriptional and replicational nucleosome assembly, as demonstrated for Ustilago U1, became an unlinked gene, no longer coupled to S phase-regulated histone gene clusters, with a replication-independent and typically constitutive pattern of expression. In this RI H3 variant, the protein sequence 87–90 that allows participation in both replicative and transcriptional chromatin formation remained invariant as demonstrated by a Tree-Of-Life evolutionary analysis (6). This characteristic results in the transcription-induced displacement and linked turnover of replacement H3 variants, as demonstrated for plants (26) and now for Ustilago histone H3.1 (Fig. 5E).

Thus, the identification and characterization of the RI and RC H3 variants in Ustilago does not reveal any new ways in which these histone variants may regulate gene expression. Rather, it illustrates how conserved the nucleosome assembly processes are across the full spectrum of eukaryotic evolution. Two distinct processes arose when early eukaryotes started packaging their DNA in nucleosomes, and these processes have continued to coexist: the addition of new nucleosomes on newly replicated DNA and the formation of replacement nucleosomes across transcribed genes in chromatin. We can only speculate that it is the increased complexity of multicellular animals, plants, and basidiomycetes that made it advantageous to duplicate H3 genes and to regulate independently the production of distinct functional H3 variant proteins.

Ustilago may be a suitable model system in which the basis of this advantage can be studied. Experimentally, it offers many of the opportunities of the S. cerevisiae for genetic analysis and molecular manipulation that have made budding yeast such a powerful tool for the study of eukaryotic cells (11, 12, 29, 3537). As shown here, it has single RC and RI H3 genes that look and behave in all aspects like the analogous genes in animals and plants. In addition, the Ustilago genome has single genes for each of the essential histone types. Histone H4 (102 amino acids) (GenBank UM02710.1) is divergently transcribed from the 135-residue H3.2 gene U2 to which it is linked (Fig. 1A). In addition to the unlinked H3.1 gene U1, Ustilago contains a single centromeric cenH3 (139 residues) on chromosome 19 (locus UM05257.1) and H2A.Z (134 residues) on chromosome 1 (locus UM01504.1). The H2A (135 residues) and H2B (141 residues) genes are paired on chromosome 3 (locus UM01504.1-UM01505.1). The similarities in histone polypeptide size (range 134–141, except for H4) prevent analysis of total histone extracts by SDS gel electrophoresis. We used the combination of reversed phase HPLC fractionation and AUT gel electrophoresis to study the histone H3.1 and H3.2 protein variants.

Histone H3 Acetylation

Acetylation levels of the Ustilago histone H3 variants,10−30% higher in the RI H3.1 protein than in H3.2 histone, ranged between 0.9 and 1.7 acetylated lysine per polypeptide chain, depending on culture conditions. This is slightly lower than the steady state levels of 1.8–2.1 in S. cerevisiae (38). Lysine labeling revealed much higher levels of acetylation in newly synthesized H3 for H3.1 with 3.1 ± 0.4 (n = 5) and for H3.2 with 2.7 ± 0.3 (n = 5) acetylated lysines (Fig. 5). In each case, nonacetylated forms did not exist immediately following histone synthesis. This suggested that each nH3 polypeptide was quantitatively acetylated at one particular lysine. The level and pattern of acetylation in AUT fluorographs (Figs. 2B, 4, and 5) suggests that, in addition, N-terminal lysines 9, 14, 18, 23, and 27 are acetylated to a higher extent in new H3 than in bulk H3 protein. In yeasts, high levels of acetylation of lysine 56 have been reported (39, 40). Histone acetyltransferase Rtt109 is thought to be responsible for the transient complete acetylation of H3K56 during nucleosome assembly in replicative chromatin, during DNA repair, or associated with transcription (4047). Support for the involvement of H3K56 acetylation comes from the increased acetylation of new H3.2 protein under conditions of replicative stress induced by hydroxyurea (lane HU-n in Fig. 6B), as reported for S. cerevisiae (41). Study of the sites and extent of lysine acetylation in new and matured H3 proteins of U. maydis and S. cerevisiae, separated by reversed phase HPLC, is in progress and will be reported elsewhere.

Are Both Histone H3 Variants of Ustilago Essential?

The multiplicity of RC and RI H3 genes in animals and plants prevents one from addressing experimentally, by gene knock-out, the simple but important question: “Can the cell live with just one of the functionally distinct histone H3 variant forms?” Full knock-out analysis for the two RC and two RI H3 genes of diploid Tetrahymena has been reported (9). Remarkably, neither H3 variant appeared essential under vegetative growth conditions. However, reduced availability of new H3 protein caused reduction in growth rates, whereas for as yet unresolved reasons, the RI H3 variant appears to be required to produce viable sexual progeny (9).

In haploid Ustilago, gene disruption of the single U1 and U2 loci is relatively efficient. Following curing of the initial heterokaryons, which grew like WT cells, by continued subculture under selection, viable and stable U1KO and U2KO homokaryon strains were isolated that did not produce any histone H3.1 or H3.2 protein, respectively (Fig. 6C). Synthesis and acetylation of the single H3 variant appeared unaffected. In U1KO cells, the amount of H3.2 protein per cell was approximately the same as the combined amount of H3.1 and H3.2 protein per WT cell (Fig. 6C). The cell doubling time increased by ∼25% (Fig. 6H), consistent with the ∼25% steady state level of H3.1 protein (Figs. 2B, 3, and 6). Thus no effect was detected from the U1 gene knock-out in vegetatively growing cells other than the growth rate limitation because of the reduction in total H3 synthesis. The similar effect was seen in U2KO strains where cell doubling rates were increased more than 2-fold (Fig. 6H) when the major source of H3 protein, RC H3.2, was deleted. In Tetrahymena, a similar reduction in growth rate was observed in RC H3 knockouts, although this effect could be partially compensated for by up-regulation of a RI H3 locus (9). Such an effect on U1 expression in U2KO strains was not detected in Ustilago. In stationary cultures, the only difference observed between WT and knock-out strains was an earlier browning (i.e. dying) of the KO cells. However, contrary to the expectation based on the synthesis and incorporation of H3 variant proteins in stationary cells (Fig. 6D), this effect was stronger for U2KO cells where H3.1 incorporation continued than for U1KO strains where no histone H3 protein was incorporated into the chromatin of nonproliferating cells (lane U1KO-Stat in Fig. 6D). Nucleosomal density differences in the chromatin of these knock-out strains are being investigated in an attempt to identify the basis for this effect.

Acknowledgments

We gratefully thank Kevin McCluskey (Fungal Genetics Stock Center, University of Missouri, Kansas City, MO), Scott Gold (University of Georgia, Athens, GA), Michael Feldbrügge (University of Düsseldorf, Düsseldorf, Germany), and Jörg Kämper and Regine Kahmann (University of Marburg, Marburg, Germany) for providing strains, plasmids, and technical and scientific advice.

*

This work was supported by Missouri Life Sciences Research Board Award 13254 (to J. H. W.).

2
The abbreviations used are:
RC
replication-coupled
AcK
acetylated lysine
AUT
acid urea Triton
qRT
quantitative reverse transcription
RI
replication-independent
SD
synthetic dextrose
ppi
peptidyl-prolyl isomerase
CBX
carboxin
LB
left border
RB
right border
n
new
m
main.

REFERENCES

  • 1. Urban M. K., Zweidler A. (1983) Dev. Biol. 95, 421–428 [DOI] [PubMed] [Google Scholar]
  • 2. Ridsdale J. A., Davie J. R. (1987) Nucleic Acids Res. 15, 1081–1096 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Lewis P. W., Elsaesser S. J., Noh K. M., Stadler S. C., Allis C. D. (2010) Proc. Natl. Acad. Sci. U.S.A. 107, 14075–14080 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Elsaesser S. J., Goldberg A. D., Allis C. D. (2010) Curr. Opin. Genet. Dev. 20, 110–117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Takayama Y., Takahashi K. (2007) Nucleic Acids Res. 35, 3223–3237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Waterborg J. H. (2011) Biochem. Cell Biol., in press [Google Scholar]
  • 7. Thatcher T. H., MacGaffey J., Bowen J., Horowitz S., Shapiro D. L., Gorovsky M. A. (1994) Nucleic Acids Res. 22, 180–186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Waterborg J. H., Robertson A. J. (1996) J. Mol. Evol. 43, 194–206 [DOI] [PubMed] [Google Scholar]
  • 9. Cui B., Liu Y., Gorovsky M. A. (2006) Mol. Cell. Biol. 26, 7719–7730 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Ahmad K., Henikoff S. (2002) Mol. Cell 9, 1191–1200 [DOI] [PubMed] [Google Scholar]
  • 11. Kämper J., Kahmann R., Bölker M., Ma L. J., Brefort T., Saville B. J., Banuett F., Kronstad J. W., Gold S. E., Müller O., Perlin M. H., Wösten H. A., de Vries R., Ruiz-Herrera J., Reynaga-Peña C. G., Snetselaar K., McCann M., Pérez-Martín J., Feldbrügge M., Basse C. W., Steinberg G., Ibeas J. I., Holloman W., Guzman P., Farman M., Stajich J. E., Sentandreu R., González-Prieto J. M., Kennell J. C., Molina L., Schirawski J., Mendoza-Mendoza A., Greilinger D., Münch K., Rössel N., Scherer M., Vranes M., Ladendorf O., Vincon V., Fuchs U., Sandrock B., Meng S., Ho E. C., Cahill M. J., Boyce K. J., Klose J., Klosterman S. J., Deelstra H. J., Ortiz-Castellanos L., Li W., Sanchez-Alonso P., Schreier P. H., Häuser-Hahn I., Vaupel M., Koopmann E., Friedrich G., Voss H., Schlüter T., Margolis J., Platt D., Swimmer C., Gnirke A., Chen F., Vysotskaia V., Mannhaupt G., Güldener U., Münsterkötter M., Haase D., Oesterheld M., Mewes H. W., Mauceli E. W., DeCaprio D., Wade C. M., Butler J., Young S., Jaffe D. B., Calvo S., Nusbaum C., Galagan J., Birren B. W. (2006) Nature 444, 97–101 [DOI] [PubMed] [Google Scholar]
  • 12. Brachmann A., König J., Julius C., Feldbrügge M. (2004) Mol. Genet. Genomics 272, 216–226 [DOI] [PubMed] [Google Scholar]
  • 13. García-Muse T., Steinberg G., Pérez-Martín J. (2003) Eukaryot. Cell 2, 494–500 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Waterborg J. H. (1990) J. Biol. Chem. 265, 17157–17161 [PubMed] [Google Scholar]
  • 15. Waterborg J. H. (2002) in The Protein Protocols Handbook (Walker J. M. ed.), 2nd edition, pp. 103–111, Humana Press, Totowa, NJ [Google Scholar]
  • 16. Waterborg J. H. (2002) in The Protein Protocols Handbook (Walker J. M. ed.), 2nd edition, pp. 113–123, Humana Press, Totowa, NJ [Google Scholar]
  • 17. Waterborg J. H. (1998) J. Biol. Chem. 273, 27602–27609 [DOI] [PubMed] [Google Scholar]
  • 18. Waterborg J. H., Robertson A. J., Tatar D. L., Borza C. M., Davie J. R. (1995) Plant Physiol. 109, 393–407 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Flor-Parra I., Vranes M., Kämper J., Pérez-Martín J. (2006) Plant Cell 18, 2369–2387 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Scherer M., Heimel K., Starke V., Kämper J. (2006) Plant Cell 18, 2388–2401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Tsukuda T., Carleton S., Fotheringham S., Holloman W. K. (1988) Mol. Cell. Biol. 8, 3703–3709 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Stewart C. N., Jr., Via L. E. (1993) BioTechniques 14, 748–750 [PubMed] [Google Scholar]
  • 23. Pitkin J. W., Panaccione D. G., Walton J. D. (1996) Microbiology 142, 1557–1565 [DOI] [PubMed] [Google Scholar]
  • 24. Kojic M., Mao N., Zhou Q., Lisby M., Holloman W. K. (2008) Mol. Microbiol. 67, 1156–1168 [DOI] [PubMed] [Google Scholar]
  • 25. Zweidler A. (1980) Dev. Biochem. 15, 47–56 [Google Scholar]
  • 26. Waterborg J. H. (1993) J. Biol. Chem. 268, 4912–4917 [PubMed] [Google Scholar]
  • 27. Waterborg J. H. (1991) Plant Physiol. 96, 453–458 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Waterborg J. H. (1992) Plant Mol. Biol. 18, 181–187 [DOI] [PubMed] [Google Scholar]
  • 29. Steinberg G., Perez-Martin J. (2008) Trends Cell Biol. 18, 61–67 [DOI] [PubMed] [Google Scholar]
  • 30. Zweidler A. (1978) Methods Cell Biol. 17, 223–233 [PubMed] [Google Scholar]
  • 31. Ridsdale J. A., Rattner J. B., Davie J. R. (1988) Nucleic Acids Res. 16, 5915–5926 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Waterborg J. H., Kapros T. (2002) Biochem. Cell Biol. 80, 279–293 [DOI] [PubMed] [Google Scholar]
  • 33. Waterborg J. H. (2002) Biochem. Cell Biol. 80, 363–378 [DOI] [PubMed] [Google Scholar]
  • 34. Kapros T., Robertson A. J., Waterborg J. H. (1995) Plant Mol. Biol. 28, 901–914 [DOI] [PubMed] [Google Scholar]
  • 35. Holloman W. K., Schirawski J., Holliday R. (2008) Fungal Genet. Biol. 45, (Suppl. 1) S31–S39 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Holloman W. K., Schirawski J., Holliday R. (2007) Trends Microbiol. 15, 525–529 [DOI] [PubMed] [Google Scholar]
  • 37. Ruiz-Herrera J., Leon C. G., Guevara-Olvera L., Carabez-Trejo A. (1995) Microbiology 141, 695–703 [Google Scholar]
  • 38. Waterborg J. H. (2000) J. Biol. Chem. 275, 13007–13011 [DOI] [PubMed] [Google Scholar]
  • 39. Garcia B. A., Hake S. B., Diaz R. L., Kauer M., Morris S. A., Recht J., Shabanowitz J., Mishra N., Strahl B. D., Allis C. D., Hunt D. F. (2007) J. Biol. Chem. 282, 7641–7655 [DOI] [PubMed] [Google Scholar]
  • 40. Adkins M. W., Carson J. J., English C. M., Ramey C. J., Tyler J. K. (2007) J. Biol. Chem. 282, 1334–1340 [DOI] [PubMed] [Google Scholar]
  • 41. Minard L. V., Williams J. S., Walker A. C., Schultz M. C. (2011) J. Biol. Chem. 286, 7082–7092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Tang Y., Holbert M. A., Delgoshaie N., Wurtele H., Guillemette B., Meeth K., Yuan H., Drogaris P., Lee E. H., Durette C., Thibault P., Verreault A., Cole P. A., Marmorstein R. (2011) Structure 19, 221–231 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Aslam A., Logie C. (2010) PLoS One 5, e10851 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Masumoto H., Hawke D., Kobayashi R., Verreault A. (2005) Nature 436, 294–298 [DOI] [PubMed] [Google Scholar]
  • 45. Thaminy S., Newcomb B., Kim J., Gatbonton T., Foss E., Simon J., Bedalov A. (2007) J. Biol. Chem. 282, 37805–37814 [DOI] [PubMed] [Google Scholar]
  • 46. Agez M., Chen J., Guerois R., van Heijenoort C., Thuret J. Y., Mann C., Ochsenbein F. (2007) Structure 15, 191–199 [DOI] [PubMed] [Google Scholar]
  • 47. Xhemalce B., Miller K. M., Driscoll R., Masumoto H., Jackson S. P., Kouzarides T., Verreault A., Arcangioli B. (2007) J. Biol. Chem. 282, 15040–15047 [DOI] [PubMed] [Google Scholar]
  • 48. Luger K., Mäder A. W., Richmond R. K., Sargent D. F., Richmond T. J. (1997) Nature 389, 251–260 [DOI] [PubMed] [Google Scholar]
  • 49. Waterborg J. H. (1990) Electrophoresis 11, 638–641 [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES